Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: A randomized double-blind trial

International Journal of Dermatology

Volumn 51, Issue 11, 2012, Pages 1371-1378

  Sonthalia, Sidharth ^a   Singal, Archana ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; FLUCONAZOLE; TACROLIMUS;

ADULT; ANTIMICROBIAL THERAPY; APPLICATION SITE BURNING; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LICHEN PLANUS; MALE; MOUTH LICHEN PLANUS; OINTMENT; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CLOBETASOL; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MALE; OINTMENTS; TACROLIMUS;

EID: 84867687319     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05459.x     Document Type: Article

References (27)

1. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission and malignant association. Oral Surg Oral Med Oral Pathol 1985; 60: 30-34.
2. Pindborg JJ, Mehta FS, Daftary DK, et al. Prevalence of oral lichen planus among 7639 Indian villagers in Kerala, South India. Acta Derm Venereol 1972; 52: 216-220.
3. Bhonsle RB, Pindborg JJ, Gupta PC, et al. Incidence rate of oral lichen planus among Indian villagers. Acta Derm Venereol 1979; 5: 255-257.
4. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 40-51.
5. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13: 350-365.
6. Van der Meij EH, Schepman KP, Smeele LE, et al. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 307-310.
7. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 164-178.
8. Hodgson T, Sahni N, Kaliakatsou F, et al. Longterm efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol 2003; 1325: 466-470.
9. Kaliakatsou F, Hodgson TA, Lewsey JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002; 46: 35-41.
10. Thomson MA, Hamburger J, Stewart DG, Lewis HM. Treatment of erosive oral lichen planus with topical tacrolimus. J Dermatolog Treat 2004; 15: 308-314.
11. Lozada-Nur FI, Sroussi HY. Tacrolimus powder in orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 744-749.
12. Byrd JA, Davis MD, Bruce AJ, et al. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol 2004; 140: 1508-1512.
13. Morrison L, Kratochvil FJ III, Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002; 47: 617-620.
14. Rozycki TW, Rogers RS III, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 2002; 46: 27-34.
15. Lener EV, Brieva J, Schachter M, et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001; 137: 419-422.
16. Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: response to topical therapy with tacrolimus. Br J Dermatol 1999; 140: 338-342.
17. Olivier V, Lacour JP, Mousnier A, et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol 2002; 138: 1335-1338.
18. Piboonniyom SO, Treister N, Pitiphat W, Woo SB. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 696-703.
19. López-Jornet P, Camacho-Alonso F, Salazar-Sanchez N. Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update. J Oral Pathol Med 2010; 39: 201-205.
20. Laeijendecker R, Tank B, Dekker SK, Neumann HA. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 2006; 86: 227-229.
21. Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 187-193.
22. Corrocher G, Di Lorenzo G, Martinelli N, et al. Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. J Clin Periodontol 2008; 35: 244-249.
23. Ruzicka T, Assmann T, Homey B. Tacrolimus: the drug for the turn of the millennium. Arch Dermatol 1999; 135: 574-580.
24. Ruzicka T, Assmann T, Lebevohl M. Potential future dermatological indications for tacrolimus ointment. Eur J Dermatol 2003; 13: 331-342.
25. Lo Muzio L, della Valle A, Mignogna MD, et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med 2001; 30: 611-617.
26. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994; 77: 598-604.
27. Berger TG, Duvic M, Van Voorhees AS, et al. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 2006; 54: 818-823.